Carlsson Björn, Sadeghi Arian, Bengtsson Mats, Wagenius Gunnar, Tötterman Thomas H
Clinical Immunology Division, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
J Immunother. 2008 Sep;31(7):633-43. doi: 10.1097/CJI.0b013e3181822097.
The generation of T cells with specific reactivity against tumor-associated antigens is prerequisite for adoptive transfer therapy. Melanoma-specific lymphocyte cultures can be established from tumor-infiltrating lymphocytes (TILs) by in vitro culture with high levels of interleukin-2. In this report, we present TIL data originating from 728 attempted cultures from 33 consecutive melanoma biopsy specimens originating from 30 patients. Cultures were analyzed for the presence of interferon gamma (IFNgamma)-producing cells upon stimulation with a panel of HLA-ABC semimatched melanoma cell lines. We sought to find whether such cell lines could be used to analyze TIL reactivity. Cell lines were used as stimulators to circumvent the need for autologous primary tumor cells. Melanoma-reactive cultures were identified by flow cytometry in 25 of the 30 patients. Four hundred forty-four of 728 (60.9%) cultures contained TILs at the end of experiment. Ninety-one of 318 cultures (28.6%) contained IFNgamma-producing cells after stimulation. In HLA-A0201 patients IFNgamma analysis was complemented with melanoma-specific tetramer staining. All but one HLA-A0201 patient had MART-1/Melan-A27-35-directed TILs, with frequencies ranging from 0.1% to 90% of CD8 cells. In addition, tetramer analysis also identified TILs directed against gp100, Tyrosinase, and Her2Neu. Tumor material was collected via needle biopsy in 16 cases and surgery in 18 cases. Overall, surgical material generated more cultures positive for T cells. The described methods are efficient in characterizing clinically relevant melanoma-reactive TILs.
产生对肿瘤相关抗原具有特异性反应性的T细胞是过继性转移治疗的前提条件。通过在高水平白细胞介素-2存在下进行体外培养,可以从肿瘤浸润淋巴细胞(TIL)中建立黑色素瘤特异性淋巴细胞培养物。在本报告中,我们展示了来自30例患者的33个连续黑色素瘤活检标本的728次尝试培养的TIL数据。在用一组HLA-ABC半匹配的黑色素瘤细胞系刺激后,分析培养物中是否存在产生干扰素γ(IFNγ)的细胞。我们试图确定这样的细胞系是否可用于分析TIL反应性。使用细胞系作为刺激物以避免对自体原发性肿瘤细胞的需求。通过流式细胞术在30例患者中的25例中鉴定出黑色素瘤反应性培养物。在实验结束时,728个培养物中的444个(60.9%)含有TIL。在刺激后,318个培养物中的91个(28.6%)含有产生IFNγ的细胞。在HLA-A0201患者中,IFNγ分析辅以黑色素瘤特异性四聚体染色。除1例HLA-A0201患者外,所有患者均有针对MART-1/Melan-A27-35的TIL,频率范围为CD8细胞的0.1%至90%。此外,四聚体分析还鉴定出针对gp100、酪氨酸酶和Her2Neu的TIL。16例通过针吸活检收集肿瘤材料,18例通过手术收集。总体而言,手术材料产生的T细胞阳性培养物更多。所描述的方法在表征临床上相关的黑色素瘤反应性TIL方面是有效的。